Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;27(4):267-270.
doi: 10.1007/s40292-020-00381-2. Epub 2020 Apr 23.

Renal Denervation in Daily Practice: If So, How?

Dominic Millenaar  1 , Insa Emrich  2 , Felix Mahfoud  2
Affiliations
Editorial

Renal Denervation in Daily Practice: If So, How?

Dominic Millenaar et al. High Blood Press Cardiovasc Prev. 2020 Aug.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Revised flowchart for patient selection suitable for RDN, focusing on shared decision making. ABPM ambulatory blood pressure monitoring, BP blood pressure, CV cardiovascular, GP general physician, RDN renal denervation
See this image and copyright information in PMC

Comment on

References

    1. Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317:165–182. doi: 10.1001/jama.2016.19043. - DOI - PubMed
    1. Judd E, Calhoun DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens. 2014;28:463–468. doi: 10.1038/jhh.2013.140. - DOI - PMC - PubMed
    1. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the symplicity HTN-1 study. Lancet (London, England) 2014;383:622–629. doi: 10.1016/S0140-6736(13)62192-3. - DOI - PubMed
    1. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (London, England) 2010;376:1903–1909. doi: 10.1016/S0140-6736(10)62039-9. - DOI - PubMed
    1. Azizi M, Schmieder RE, Mahfoud F, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet (London, England) 2018;391:2335–2345. doi: 10.1016/S0140-6736(18)31082-1. - DOI - PubMed

LinkOut - more resources